Azenta, Inc.

AZTA Healthcare Medical Instruments & Supplies

Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

34.09 2.43 −6.65%
Market cap
$1.6B
P/E
0.0×
Fwd P/E
−6.2×
Dividend yield
—
F-score
7/9
Altman Z
3.85
Beneish M
−2.63
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
2.21 2.57 1.63 1.88
P/FCF ratio
34.28 49.39 32.39 116.96
P/Operating CF
605.41 73.28 72.03 799.79
P/B ratio
0.76 0.89 0.63 0.77
EV/Sales
1.72 1.96 1.07 1.43
EV/EBITDA
31.13 38.90 20.25 31.24
EV/FCF
26.63 37.69 21.32 88.82
Current Ratio
2.98 2.92 2.83 2.50
Net Debt/EBITDA
(21.35) (68.25) 127.09 (36.48)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(4.49%) (4.03%) (18.69%) (10.78%)
Free Cash Flow Yield
2.92% 2.02% 3.09% 0.85%
Free Cash Flow per Share
(0.12) 0.32 0.13 (0.11)
Book value per Share
37.75 37.34 33.75 33.35
Free Cash Flow
(5.69) 14.66 6.11 (5.19)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates